Overall survival after diagnosis survival rate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Lymph Nodes Cells, Cultured Bile Ducts, Intrahepatic

Organisms2

Mice, Inbred C57BL Mice, Inbred BALB C

Diseases69

Neoplasm Recurrence, Local Lung Neoplasms Breast Neoplasms Adenocarcinoma Neoplasm Metastasis Liver Neoplasms Lymphatic Metastasis Disease Progression Recurrence Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Brain Neoplasms Colorectal Neoplasms Carcinoma, Hepatocellular Stomach Neoplasms Carcinoma Ovarian Neoplasms Pancreatic Neoplasms Neoplasm Invasiveness Bone Neoplasms Esophageal Neoplasms Melanoma Multiple Myeloma Sarcoma Head and Neck Neoplasms Kidney Neoplasms Leukemia, Myeloid, Acute Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin Postoperative Complications Neoplasms Glioblastoma Hodgkin Disease Rectal Neoplasms Skin Neoplasms Carcinoma, Renal Cell Nasopharyngeal Neoplasms Prostatic Neoplasms Osteosarcoma Acute Disease Bile Duct Neoplasms Soft Tissue Neoplasms Central Nervous System Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Cholangiocarcinoma Lymphoma, Follicular Glioma Peritoneal Neoplasms Urinary Bladder Neoplasms Neoplasm, Residual Colonic Neoplasms Disease Models, Animal Neoplasms, Second Primary Carcinoma, Small Cell Lymphoma Neutropenia Leukemia, Lymphocytic, Chronic, B-Cell Graft vs Host Disease Myelodysplastic Syndromes Rhabdomyosarcoma Neoplasms, Glandular and Epithelial Lymphoma, B-Cell Laryngeal Neoplasms Carcinoma, Pancreatic Ductal Oropharyngeal Neoplasms Mouth Neoplasms Pleural Neoplasms Gastrointestinal Neoplasms Carcinoma, Transitional Cell

Chemicals and Drugs55

Tumor Markers, Biological Antineoplastic Agents Cisplatin Fluorouracil Vincristine Cyclophosphamide Doxorubicin Prednisone Deoxycytidine Etoposide Antimetabolites, Antineoplastic Organoplatinum Compounds Antibodies, Monoclonal, Humanized Carboplatin Vinblastine Paclitaxel Leucovorin Dacarbazine Taxoids Methotrexate Antibodies, Monoclonal Cytarabine Camptothecin Bleomycin Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents, Alkylating Receptor, erbB-2 Melphalan Procarbazine Neoplasm Proteins Ifosfamide Epirubicin Antineoplastic Agents, Hormonal Ki-67 Antigen Receptors, Estrogen Immunosuppressive Agents Thalidomide RNA, Messenger Tumor Suppressor Protein p53 Antineoplastic Agents, Phytogenic Receptors, Progesterone Quinazolines Anthracyclines Mitoxantrone Proto-Oncogene Proteins Niacinamide Tegafur Receptor, Epidermal Growth Factor Protein Kinase Inhibitors Mechlorethamine Platinum Compounds Tamoxifen Biological Markers Phenylurea Compounds Lomustine

Analytical, Diagnostic and Therapeutic Techniques and Equipment99

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Prognosis Retrospective Studies Kaplan-Meier Estimate Neoplasm Staging Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Combined Modality Therapy Proportional Hazards Models Chemotherapy, Adjuvant Multivariate Analysis Prospective Studies Immunohistochemistry Risk Factors Predictive Value of Tests Drug Administration Schedule Radiotherapy, Adjuvant Remission Induction Cohort Studies Neoadjuvant Therapy Salvage Therapy Risk Assessment Radiotherapy Dosage Actuarial Analysis Sensitivity and Specificity Chemoradiotherapy Registries Delayed Diagnosis Transplantation, Homologous Radiotherapy Transplantation, Autologous Early Diagnosis Neoplasm Grading Life Tables Hepatectomy Prenatal Diagnosis Hematopoietic Stem Cell Transplantation Dose Fractionation Lymph Node Excision Liver Transplantation Incidence Tomography, X-Ray Computed Randomized Controlled Trials as Topic Treatment Failure Chi-Square Distribution Clinical Trials, Phase III as Topic SEER Program Tissue Array Analysis Clinical Trials as Topic Reverse Transcriptase Polymerase Chain Reaction Reoperation Tumor Burden Probability Biopsy Analysis of Variance Infusions, Intravenous Chemoembolization, Therapeutic Induction Chemotherapy Gastrectomy Palliative Care Immunoenzyme Techniques Patient Selection Gene Expression Profiling Polymerase Chain Reaction Severity of Illness Index Reproducibility of Results Kidney Transplantation Cause of Death Chemoradiotherapy, Adjuvant Esophagectomy Brachytherapy Diagnosis Transplantation Conditioning Preoperative Care Cranial Irradiation Case-Control Studies Stem Cell Transplantation Disease Models, Animal Clinical Trials, Phase II as Topic Statistics, Nonparametric Bone Marrow Transplantation Regression Analysis Biopsy, Needle Pneumonectomy Feasibility Studies In Situ Hybridization, Fluorescence Radiosurgery Magnetic Resonance Imaging Blotting, Western Cystectomy Radiotherapy, Conformal Risk Cardiopulmonary Resuscitation Positron-Emission Tomography Radiotherapy, High-Energy Mastectomy

Phenomena and Processes16

Cell Survival Graft Survival Time Factors Apoptosis Sensitivity and Specificity Gene Expression Regulation, Neoplastic Mutation Chi-Square Distribution Drug Resistance, Neoplasm Signal Transduction Cell Proliferation Probability Dose-Response Relationship, Drug Graft Rejection Pregnancy Risk

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Life Tables Incidence SEER Program Cause of Death Radiotherapy, Conformal

Named Groups3

Infant, Newborn Tissue Donors Survivors

Health Care42

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Retrospective Studies Kaplan-Meier Estimate Follow-Up Studies Proportional Hazards Models Multivariate Analysis Prospective Studies Risk Factors Predictive Value of Tests Cohort Studies Age Factors Risk Assessment Actuarial Analysis Sensitivity and Specificity Registries Life Tables Incidence Randomized Controlled Trials as Topic Treatment Failure Chi-Square Distribution Clinical Trials, Phase III as Topic SEER Program Clinical Trials as Topic Probability Analysis of Variance Palliative Care Patient Selection Severity of Illness Index Reproducibility of Results Cause of Death Preoperative Care Case-Control Studies Sex Factors Clinical Trials, Phase II as Topic Statistics, Nonparametric Regression Analysis Feasibility Studies Risk Comorbidity

Geographicals3

United States Japan Italy

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Rate Disease-Free Survival Survival Analysis Cell Survival Treatment Outcome Prognosis Retrospective Studies Kaplan-Meier Estimate Neoplasm Staging Survival Antineoplastic Combined Chemotherapy Protocols Follow-Up Studies Combined Modality Therapy Graft Survival Time Factors Neoplasm Recurrence, Local Proportional Hazards Models Tumor Markers, Biological Lung Neoplasms Chemotherapy, Adjuvant Multivariate Analysis Breast Neoplasms Antineoplastic Agents Adenocarcinoma Neoplasm Metastasis Cisplatin Prospective Studies Liver Neoplasms Fluorouracil Lymphatic Metastasis Disease Progression Immunohistochemistry Vincristine Cyclophosphamide Risk Factors Doxorubicin Recurrence Predictive Value of Tests Drug Administration Schedule Radiotherapy, Adjuvant Carcinoma, Squamous Cell Remission Induction Cohort Studies Carcinoma, Non-Small-Cell Lung Brain Neoplasms Colorectal Neoplasms Prednisone Age Factors Deoxycytidine Carcinoma, Hepatocellular Neoadjuvant Therapy Stomach Neoplasms Carcinoma Salvage Therapy Ovarian Neoplasms Pancreatic Neoplasms Risk Assessment Etoposide Radiotherapy Dosage Neoplasm Invasiveness Actuarial Analysis Apoptosis Sensitivity and Specificity Chemoradiotherapy Registries Gene Expression Regulation, Neoplastic Bone Neoplasms Esophageal Neoplasms Antimetabolites, Antineoplastic Cell Line, Tumor Delayed Diagnosis Melanoma Transplantation, Homologous Radiotherapy Organoplatinum Compounds Transplantation, Autologous Early Diagnosis Antibodies, Monoclonal, Humanized Carboplatin Neoplasm Grading Vinblastine Life Tables Multiple Myeloma Paclitaxel Leucovorin Dacarbazine Taxoids Hepatectomy Prenatal Diagnosis Sarcoma Head and Neck Neoplasms Kidney Neoplasms Methotrexate Leukemia, Myeloid, Acute Antibodies, Monoclonal Hematopoietic Stem Cell Transplantation Dose Fractionation Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin Lymph Node Excision

No FAQ available that match "overall survival after diagnosis survival rate"